Pier 88 Investment Partners’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-75,146
Closed -$473K 103
2019
Q1
$473K Buy
75,146
+26,800
+55% +$188K 0.22% 73
2018
Q4
$313K Sell
48,346
-9,800
-17% -$75K 0.16% 69
2018
Q3
$483K Sell
58,146
-89,580
-61% -$681K 0.21% 65
2018
Q2
$920K Buy
147,726
+44,455
+43% +$283K 0.43% 37
2018
Q1
$707K Buy
103,271
+23,320
+29% +$148K 0.34% 43
2017
Q4
$526K Buy
79,951
+18,365
+30% +$112K 0.2% 56
2017
Q3
$342K Buy
61,586
+4,300
+8% +$29K 0.13% 78
2017
Q2
$442K Sell
57,286
-10,700
-16% -$90.4K 0.18% 55
2017
Q1
$613K Buy
67,986
+26,586
+64% +$277K 0.25% 42
2016
Q4
$448K Buy
+41,400
New +$552K 0.26% 79

Other funds holding NPTN

Pier 88 Investment Partners's NPTN Position: Q2 2019 in Review

Pier 88 Investment Partners sold out of NEOPHOTONICS CORP (NPTN) in Q2 2019, closing a stake of 75,146 shares — an estimated $473K sold.

Pier 88 Investment Partners first reported a position in NPTN in Q4 2016 and held it in 10 quarters. The position peaked at $920K in Q2 2018. 113 funds tracked by Wall St. Rank hold NPTN as of Q2 2019.

  • Pier 88 Investment Partners reported no remaining NEOPHOTONICS CORP position as of Q2 2019 after selling out during the quarter.
  • Pier 88 Investment Partners sold 75,146 NEOPHOTONICS CORP shares in Q2 2019, an estimated $473K.
  • Pier 88 Investment Partners first reported a position in NEOPHOTONICS CORP in Q4 2016 and held it in 10 quarters.
  • Pier 88 Investment Partners's NEOPHOTONICS CORP position peaked at $920K in Q2 2018.
  • 113 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2019.

Based on Pier 88 Investment Partners's 13F filing for Q2 2019, filed 8 Aug 2019.